activins and Muscular Dystrophy, Duchenne

activins has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cannell, M; Castonguay, R; Davies, MV; Grinberg, AV; Keates, S; Kumar, R; Li, J; Liharska, K; Mulivor, AW; Pearsall, RS; Sako, D; Spaits, M; Suragani, RNVS; Troy, ME; Wallner, S; Widrick, J	1

Other Studies

1 other study(ies) available for activins and Muscular Dystrophy, Duchenne

Article	Year
Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. Scientific reports, 2019, 08-06, Volume: 9, Issue:1 Topics: Activins; Animals; Bone Morphogenetic Proteins; Charcot-Marie-Tooth Disease; Disease Models, Animal; Follistatin; Growth Differentiation Factors; Humans; Hypertrophy; Ligands; Male; Mice; Mice, Inbred mdx; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myostatin; Receptors, IgG; Recombinant Fusion Proteins	2019

Article

Year

Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease.

Scientific reports, 2019, 08-06, Volume: 9, Issue:1

Topics: Activins; Animals; Bone Morphogenetic Proteins; Charcot-Marie-Tooth Disease; Disease Models, Animal; Follistatin; Growth Differentiation Factors; Humans; Hypertrophy; Ligands; Male; Mice; Mice, Inbred mdx; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myostatin; Receptors, IgG; Recombinant Fusion Proteins

2019